Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer
2010
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome
2011
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
Trisomy represses ApcMin -mediated tumours in mouse models of Down’s syndrome
2008 Nature
Down syndrome and the complexity of genome dosage imbalance
2016
Germline development from human pluripotent stem cells toward disease modeling of infertility
2012 StandoutNobel
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Transcription of two human genes from a bidirectional endogenous retrovirus promoter
2005
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
2006 StandoutNature
Induced Pluripotent Stem Cells: Past, Present, and Future
2012 StandoutNobel
Induction of pluripotency by defined factors
2010 StandoutNobel
Chitosan-based hydrogels for controlled, localized drug delivery
2009 Standout
Modeling familial Alzheimer's disease with induced pluripotent stem cells
2011 StandoutNobel
Alzheimer's disease
2011 Standout
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
The Use of Induced Pluripotent Stem Cells in Drug Development
2011 StandoutNobel
Microglial cell origin and phenotypes in health and disease
2011 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancer
2008
Takotsubo Cardiomyopathy: A Unique Cardiomyopathy With Variable Ventricular Morphology
2010
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Upping the Ante: Recent Advances in Direct Reprogramming
2009
A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine
2007
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
2010
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy
2011 Standout
Facial shape differences between rats selected for tame and aggressive behaviors
2017 StandoutNobel
Chromosome 21 and Down syndrome: from genomics to pathophysiology
2004 Standout
Induced pluripotent stem cells and reprogramming: seeing the science through the hype
2009 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Orderly hematopoietic development of induced pluripotent stem cells via Flk‐1+ hemoangiogenic progenitors
2009 StandoutNobel
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Gene expression dysregulation domains are not a specific feature of Down syndrome
2019
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
A Fresh Look at iPS Cells
2009 StandoutNobel
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies
2006
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
Down syndrome
2020 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Mouse models of Down syndrome: gene content and consequences
2016
Interleukin-13 Protects Against Experimental Autoimmune Myocarditis by Regulating Macrophage Differentiation
2008
Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
2015
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
2009 StandoutNobel
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
Nuclear Reprogramming in Cells
2008 StandoutScienceNobel
Down Syndrome
2020 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells
2012 StandoutNobel
Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells
2005
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
2011
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome
2008
Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier
2016
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
The use of mouse models to understand and improve cognitive deficits in Down syndrome
2011
Acute upregulation of hedgehog signaling in mice causes differential effects on cranial morphology
2014
Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome
2018
Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel
2016
Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2–Knockout Mice
2004
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cardiotoxicity of Antitumor Drugs
2008
Rodent models in Down syndrome research: impact and future opportunities
2017
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells
2010 StandoutNobel
Carbonyl Reductases: The Complex Relationships of Mammalian Carbonyl- and Quinone-Reducing Enzymes and Their Role in Physiology
2006
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
2014 StandoutNobel
Works of Lisa E. Olson being referenced
Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment
2006
Trisomy for the Down syndrome ‘critical region’ is necessary but not sufficient for brain phenotypes of trisomic mice
2007
Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes
2004
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
2003
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
2004 Science